The use of a GILZ-derived peptide (containing the critical amino acids 120–123, necessary for GILZ interaction with NF-κB) counteracted neuroinflammation effectively in a mouse model of multiple sclerosis [66,67]. The gene discussed is TSC22D3; the disease is multiple sclerosis.